SGMO

#3969
Sangamo Therapeutics, Inc. Common Stock
0.26 USD
0.00%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
0.26
0.26
년간 변동
0.21
0.84
일일 변동
0.00%
월간 변동
-35.00%
6달 변화
-62.86%
년간 변동율
-65.33%
이전 종가
0.26
Open
0.26
Bid
Ask
Low
0.26
High
0.26
양
11
Open full chart

Financials

Overview 성명 Statistics
Quarterly Annual
  • Market Capitalization 107.71 M
  • Employee 183
  • Founded 1995
  • CEO Sandy Macrae
  • Website www.sangamo.com
  • Headquarter Delaware, United States
  • FIGI BBG000BHYT80
  • Industry Technology
총매출
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.95
Price to sales ratio
2.98

Sangamo Therapeutics Inc

Sangamo Therapeutics, Inc. is an American biotechnology company based in Brisbane, California, that develops cell and gene therapies for severe genetic diseases.

뉴스